Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCDC136 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | BRD7 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | TMEM248 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | RHOH | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | WDR44 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
mRNA | CTB-50L17.10 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | CDK8 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | ADRA2B | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
mRNA | RPUSD4 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | LOXL1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |